Evidence map›Paper›PMID 34281254›Full record

ReviewInternational journal of molecular sciences2021

Silver Nanoparticles and Their Antibacterial Applications.

Tamara Bruna, Francisca Maldonado-Bravo, Paul Jara, Nelson Caro

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 523 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
523citing papers in PubMed, 2 pooled it
77.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

523 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,526 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Comparison of retention rates of silver nanoparticles-based fissure sealant and conventional resin-based sealant: a one-year randomized clinical trial.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2025
    Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. RSC advances · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Review

463 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tamara BrunaCentro de Investigación Austral Biotech, Facultad de Ciencias, Universidad Santo Tomás, Avenida Ejército 146, Santiago 8320000, Chile.
Francisca Maldonado-BravoCentro de Investigación Austral Biotech, Facultad de Ciencias, Universidad Santo Tomás, Avenida Ejército 146, Santiago 8320000, Chile.
Paul JaraDepartamento de Química, Facultad de Ciencias, Universidad de Chile, Las Palmeras 3425, Ñuñoa, Santiago 7800003, Chile.
Nelson CaroCentro de Investigación Austral Biotech, Facultad de Ciencias, Universidad Santo Tomás, Avenida Ejército 146, Santiago 8320000, Chile.
Universidad Santo Tomás · CLUniversity of Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) have been imposed as an excellent antimicrobial agent being able to combat bacteria in vitro and in vivo causing infections. The antibacterial capacity of AgNPs covers Gram-negative and Gram-positive bacteria, including multidrug resistant strains. AgNPs exhibit multiple and simultaneous mechanisms of action and in combination with antibacterial agents as organic compounds or antibiotics it has shown synergistic effect against pathogens bacteria such as

Indexed as

AnimalsAnti-Bacterial AgentsBacterial InfectionsCell LineDrug DevelopmentDrug Resistance, BacterialEscherichia coliHumansMetal NanoparticlesMicrobial Sensitivity TestsNanotechnologyPseudomonas aeruginosaSilverStaphylococcus aureusAnti-Bacterial AgentsSilverantibacterial activityantibiotic alternativecytotoxicitymedical applicationssilver nanoparticles

Identifiers

PMID34281254
PMCPMC8268496
OpenAlexW3182217762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.